Alembic Pharma Completes USFDA Inspection Without Form 483 Observations
Alembic Pharmaceuticals Limited has successfully completed an unannounced onsite inspection conducted by the United States Food and Drug Administration (USFDA) at its Bioequivalence Facility in Vadodara, Gujarat.











